KLA Corporation (KLAC) Q3 2025 10-Q Quarterly Report

Filed: Oct 31, 2025Period ending Sep 30, 2025
Health Care
Optical Instruments & LensesSEC EDGAR

KLA Corporation (KLAC) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 31, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

KLA Corporation Q3 2025 10-Q Analysis

Management Discussion & Analysis

  • Working capital $6.85B as of Sep 30, 2025, up $238.2M from $6.61B on Jun 30, 2025
  • Cash, cash equivalents, and marketable securities $4.68B; $1.50B available under Revolving Credit Facility
  • Liquidity considered sufficient for working capital, capital expenditures, dividends, stock repurchases through next 12 months
  • Credit ratings: Fitch A, Moody’s A2, S&P A- as of Sep 30, 2025
  • No off-balance sheet arrangements materially impacting financial position or operations

Risk Factors

  • New export restrictions: 2025 BIS Rules incrementally restrict sales to China, adding companies to Entity List, redefining advanced DRAM, triggered by U.S. Commerce policy updates
  • Updated tax regime risk: OBBBA effective July 2025 changes GILTI and FDII rules, potentially materially increasing effective tax rate and CAMT exposure
  • Compliance risk: September 2025 Affiliates Rule imposes expanded ownership knowledge requirements on export transactions, increasing risk of violations and penalties
  • Supply chain risk: Chinese 2025 export controls on 12 rare earth elements jeopardize critical component availability, risking product delays and increased costs
  • Revenue concentration risk: China sales dropped to 33% in FY25 from 43% in FY24 due to export restrictions, threatening near-term revenue stability

KLA Corporation Q3 2025 Quarterly Financials
XBRL

Revenue

$3.2B

+13.0% YoY

Net Income

$1.1B

+18.5% YoY

Net Margin

34.9%

+164bp YoY

EPS (Diluted)

$8.47

+20.8% YoY

Operating Cash Flow

$1.2B

+16.7% YoY

Source: XBRL data from KLA Corporation Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.

Other KLA Corporation Quarterly Reports

Get deeper insights on KLA Corporation

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.